Pasar al contenido principal

MODELOS INDUCIDOS DE INESTABILIDAD CROMOSOMICA PARA EL DESARROLLO DE FARMACOS EN CANCER

PID2022-137042OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

scAbsolute: measuring single-cell ploidy and replication status

  • Schneider, Michael P.
  • Cullen, Amy E.
  • Pangonyte, Justina
  • Skelton, Jason
  • Major, Harvey
  • Van Oudenhove, Elke
  • García, María J.
  • Chaves Urbano, Blas
  • Piskorz, Anna M.
  • Brenton, James D.
  • Macintyre, Geoff
  • Markowetz, Florian
Cancer cells often exhibit DNA copy number aberrations and can vary widely in their ploidy. Correct estimation of the ploidy of single-cell genomes is paramount for downstream analysis. Based only on single-cell DNA sequencing information, scAbsolute achieves accurate and unbiased measurement of single-cell ploidy and replication status, including whole-genome duplications. We demonstrate scAbsolute's capabilities using experimental cell multiplets, a FUCCI cell cycle expression system, and a benchmark against state-of-the-art methods. scAbsolute provides a robust foundation for single-cell DNA sequencing analysis across different technologies and has the potential to enable improvements in a number of downstream analyses., We would like to acknowledge the support of The University of Cambridge and Cancer Research UK (C14303/A17197 and A19274). The research was supported by UK Research and Innovation (EP/X028054/1). MPS was supported by a Marie-Sklodowska-Curie PhD Fellowship (766030-CONTRA-H2020-MSCA-ITN-2017) and an Enrichment scheme at The Alan Turing Institute (2021/2022). MJG, BCU, and GM are hosted by the Centro Nacional de Investigaciones Oncológicas (CNIO), which is supported by the Instituto de Salud Carlos III and recognized as a 'Severo Ochoa' Centre of Excellence (ref. CEX2019-000891-S) by the Spanish Ministry of Science and Innovation (MCIN/AEI/10.13039/501100011033). This work was supported by grants to GM by the Spanish Ministry of Science and Innovation (PID2019-111356RA-I00 funded by MCIN/AEI /10.13039/501100011033 and PID2022-137042OB-I00 funded by MCIN/AEI /10.13039/501100011033 and by the European Union, ERDF "A way of making Europe"), With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000891-S)., Peer reviewed